L3W1 BA Management Flashcards

1
Q

Goals of BA treatment? (4)

A
  1. Control of BA(symp, pulmo fx)
  2. Dec/prevent comp asthma
  3. Dec mortality asthma
  4. Dec se & mortality from drugs use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Asthma Treatment depend on? (4)

A
  1. Severity asthma
  2. Pt current treatment
  3. Economic considerations
  4. Drug availability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Sympathomimetics(BA)? (short/long)

A
  1. Short acting
    - Salbutamol,Terbutaline, Fenotero
  2. Long acting
    - Salmetrol, Formetrol, Bambuterol, Olodaterol, Indacaterol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Parasympatholytic?(short/long)

A
  1. Short acting
    - Ipratropium bromide
  2. Long acting
    - Glycopyrronium, Tiotropium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Theophylline

A
  • Inhibit phosphodiestrase-> accumulation cAMP in Sm Ms

- Rare use nowadays

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Antiinflammatory drugs? (6)

A
1. Steroids:
A) Inhaled
-Beclomethasone, Budesonide, Flutecasone, Ceclesonide
B) Systemic: parenteral/oral
-Prednisolone, Betasone, Dexasone
2. Antileukotreins: 
-montelukast, xafirlukast
3. Anti-IgE:
-omalizumab
4. Steroid sparing drugs:
-azathioprine, methotrexate, cyclosporine A
5. Anti IL5
6. Anti IL13
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Asthma severity grades(severity/day/night/fev1%)

A
  • Intermittent(≤2 d/w, ≤2n/m, ≥80%)
  • Mild(>2/w, 2n/m, ≥80%)
  • Moderate(daily, >1n/w, 60-80%)
  • Severe(cont, frequent, ≤60%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Stepwise for Asthma? (5 steps)

A
Step 1
-Low ICS, SABA if needed
Step 2
-Medium ICS + LABA, LRA, theophylline
Step 3
-High ICS + LABA, LRA, theophylline
Step 4
-High ICS + LABA, LRA, theophylline, Sys low steroid
Step 5
-High ICS + LABA, LRA, theophylline, sys low steroid, tiotropium, Anti IGE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Def ASA?

A

Wheezing which not respond to initial treatment with inhaled bronchodilator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CP ASA(6)

A
  1. Pulse: >130/min
  2. RR: >30/min
  3. Intercostal indrowing
  4. Cyanosis
  5. Unable to complete a sentence
  6. Pulsus paradoxicus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Ttt ASA(7)

A
  1. Open IV line
  2. O2 inhalation
  3. 200mg hydrocortisone
  4. IV theophylline slowly(30min)
  5. Inhaled salbutamol w/wo ipratropium(nebulizer)
  6. Inhaled high doses budesonide(nebulizer)
  7. Mechanical ventilation if pt:
    - Exhausted, Hypercapnea.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ttt job asthma(3)

A
  1. Change work environment
  2. Desensitization if not possible
  3. LABA + ICS + LTRA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CP AIA(triad)

A
  1. Asthma,
  2. Chronic rhinosinusitis w nasal polyps
  3. Precipitation asthma & rhinitis att(aspirin & other NSAID)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ttt AIA(4)

A
  1. Inhaled corticosteroids,
  2. Beta(2)-adrenoceptor agonists
  3. LT modifiers
  4. COX2 inh
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ATS workshop(major ≥1, minor 2)

A
  • Cont/near-cont oral steroid
  • High-dose ICS
  • Additional daily controller
  • Use SABA daily
  • Persistent airway obs
  • FEV1 <80%
  • Diurnal variation in PF ≥ 25%
  • ≥ 1 urgent care visit per year
  • ≥3 steroid bursts per year
  • Prompt deterioration w 25% reduce steroid dose
  • Episode of near-fatal asthma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

CP EIA(7)

A
  1. Coughing
  2. Wheezing
  3. Shortness of breath
  4. Chest tightness/pain
  5. Fatigue during exercise
  6. Poor athletic performance
  7. Avoid activity (young children)
17
Q

Ttt EIA(6)

A
  1. Warming
  2. SABA 15min before exercise
  3. Ipratropium bromide 15min before exercise
  4. Inhaled corticosteroids
  5. Combination: LABA + ICS
  6. Leukotriene modifiers
18
Q

Treatment of eosinophilic asthma

A

Target Th2(allergic) asthma

19
Q

Treatments based on Phenotypes - Omalizumab

A
  • High IgE
  • Known Allergen
  • BMI
20
Q

Treatments based on Phenotypes - Mepolizumab

A
  • High Eosinophils
  • > =2 exacerbations/yr
  • On high dose ICS
21
Q

Se Omalizumab & Mepolizumab

A

Omalizumab
-anaphylaxis, malig, pain & arthralgia, inj site bruise/pain
Mepolizumab
-ms pain, fatigue, inj site bruise/pain